INDICATORS

More documents

Recommendations

Info

Kilpeläinen K., Aromaa A. and the ECHIM project (Eds.) EUROPEAN HEALTH <strong>INDICATORS</strong>: DEVELOPMENT AND INITIAL IMPLEMENTATION Final report of the ECHIM project Publications of the National Public Health Institute B 31 / 2008
Page 1: Katri Kilpeläinen, Arpo Aromaa and
Page 5 and 6: Contents ACKNOWLEDGEMENTS..........
Page 7 and 8: FOREWORD The ECHIM project was sele
Page 9 and 10: The duration of ECHIM was very shor
Page 11 and 12: 24 • Estonia: Liis Rooväli , Kat
Page 13 and 14: SUMMARY Technical information Proje
Page 15 and 16: Katri Kilpeläinen & Arpo Aromaa 1.
Page 17 and 18: Project) and previous WHO work such
Page 19 and 20: 1.4. Organisation The ECHIM Core Gr
Page 21 and 22: these and other Working Parties’
Page 23 and 24: in the early 19th century, social a
Page 25 and 26: Electronic health records Health in
Page 27 and 28: according to services produced (fun
Page 29 and 30: 4. Diagnosis-specific morbidity sta
Page 31 and 32: One of the main problems of the HfA
Page 33 and 34: 2004-2005 ECHI-2 project proposes e
Page 35 and 36: In short, the shortlist would focus
Page 37 and 38: As agreed, the NCA meeting of Janua
Page 39 and 40: 3.4. ECHI shortlist and longlist: f
Page 41 and 42: In order to create a simplified pro
Page 43 and 44: At the first meetings of the ECHIM
Page 45 and 46: 6) “(Preferred) data source(s)”
Page 47 and 48: Table 4. A Documentation Sheet for
Page 49 and 50: Documentation Sheets (version 9/200
Page 51 and 52: The definitions of ECHI indicators
Page 53 and 54:
Figure 2. Availability of ECHI shor
Page 55 and 56:
Figure 4. Availability of ECHI shor
Page 57 and 58:
Third, it is not enough to define d
Page 59 and 60:
health information situation in the
Page 61 and 62:
Overall data availability was quite
Page 63 and 64:
had a significant influence on the
Page 65 and 66:
The last questions were about the r
Page 67 and 68:
Before the implementation process c
Page 69 and 70:
The importance of national contact
Page 71 and 72:
Arpo Aromaa & Katri Kilpeläinen 6.
Page 73 and 74:
As stated in the summary of this re
Page 75 and 76:
structure will assume responsibilit
Page 77 and 78:
Arpo Aromaa & Katri Kilpeläinen 7.
Page 79 and 80:
hyperlipidemia as well as behaviour
Page 81 and 82:
7) When a suitable set of data and
Page 83 and 84:
ANNEX 1 ANNEX 1: A new release of t
Page 85 and 86:
45. Pregnant women smoking 46. Tota
Page 87 and 88:
39. Psychological well-being - ADDE
Page 89 and 90:
ANNEX 2 Calculation: 1) Eurostat: L
Page 91 and 92:
9. POPULATION BELOW POVERTY LINE AN
Page 93 and 94:
Calculation: 1) The number of fetal
Page 95 and 96:
Notes: Recognising the multi-factor
Page 97 and 98:
Notes: National case definitions ar
Page 99 and 100:
23. DEPRESSION Definition: Proporti
Page 101 and 102:
Notes: 1) Incidence refers to perso
Page 103 and 104:
Calculation: 1) European Injury Dat
Page 105 and 106:
Notes: Availability of the suicide
Page 107 and 108:
Answer categories: Yes, with no dif
Page 109 and 110:
Calculation: 1) An index or a score
Page 111 and 112:
43. BLOOD PRESSURE Definition: 1) P
Page 113 and 114:
Notes: Total alcohol consumption ca
Page 115 and 116:
Notes: WHO recommendation: daily av
Page 117 and 118:
53. WORK-RELATED HEALTH RISKS Defin
Page 119 and 120:
56. VACCINATION COVERAGE IN CHILDRE
Page 121 and 122:
60. COLON CANCER SCREENING Definiti
Page 123 and 124:
Calculation: The indicator is calcu
Page 125 and 126:
66. MEDICAL TECHNOLOGIES (CT/MRI) D
Page 127 and 128:
69. HOSPITAL DAYCASE/IN-PATIENT DIS
Page 129 and 130:
72. OTHER OUTPATIENT VISITS Definit
Page 131 and 132:
76. INSURANCE COVERAGE Definition:
Page 133 and 134:
79. 30-DAY IN-HOSPITAL CASE-FATALIT
Page 135 and 136:
Calculation: Indicator needs furthe
Page 137 and 138:
86. POLICIES ON HEALTHY NUTRITION D
Page 139 and 140:
ANNEX 3 Data availability of Health
Page 141 and 142:
Data availability of Determinants o
Page 143 and 144:
74. Medicine use, selected groups A
Page 145 and 146:
ANNEX 4 ANNEX 4: Country Specific S
Page 147 and 148:
Finally, the possible solutions for
Page 149 and 150:
selected health indicators with tim
Page 151 and 152:
costly in comparison with the added
Page 153 and 154:
Possible solutions for implementati
Page 155 and 156:
Main problems: There are problems o
Page 157 and 158:
Main problems: Overall shortage of
Page 159 and 160:
Annual forms from some health estab
Page 161 and 162:
Page 163 and 164:
Ongoing and/or expected improvement
Page 165 and 166:
Page 167 and 168:
with the Ministry of Health, the na
Page 169 and 170:
Page 171 and 172:
Main problems: The lack of cancer r
Page 173 and 174:
support is lacking. Record linkage
Page 175 and 176:
Main problems are of financial and
Page 177 and 178:
eports and policy papers. These are
Page 179 and 180:
Page 181 and 182:
Main problems: Although there are g
Page 183 and 184:
Main problems: International survey
Page 185 and 186:
Main problems: The decentralised st
Page 187 and 188:
Main problems: Resources, especiall
Page 189 and 190:
international comparison, EHIS migh
Page 191 and 192:
the Norwegian Patient Register can
Page 193 and 194:
Country Report, data availability E
Page 195 and 196:
decisions and less on political and
Page 197 and 198:
published online, but in Slovene on
Page 199 and 200:
In addition, MoH, INE, ISCIII, MARM
Page 201 and 202:
Page 203 and 204:
in 2007-2008 and financed by Health
Page 205 and 206:
Main problems: Due to UK including
Page 207 and 208:
ANNEX 5 • Demographic and socio-e
Page 209 and 210:
Content block 4: Links to indicator
Page 211 and 212:
ANNEX 6 Abbreviation EHEMU EHES EHI
Page 213:
Abbreviation MORB MRI MS / MSs MSDG
show all

INDICATORS

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?